news

Europe’s pharmaceutical packaging market to value over $35bn by 2028

2
SHARES

With the pharmaceutical industry placing greater emphasis on sustainability, as a material, paper will play a key role in Europe’s packaging and labelling market between 2023-2028, research predicts.

Europe’s pharmaceutical packaging market to value over $35bn by 2028

Europe’s pharmaceutical packaging and labelling market is projected to reach $35.78 billion in 2028, according to a report by Arizton.

 

LAST CHANCE TO REGISTER!


Rapid sterility testing is no longer optional for advanced therapies – it’s becoming operationally essential. Join this webinar to explore rapid sterility testing methods that ensure fast, reliable product release, addressing critical challenges in timely delivery and safety.

Harnessing digital PCR for rapid sterility testing

18 March 2026 | 3PM

What you’ll discover:

  • Rapid sterility testing methods that address the challenge of lengthy testing times, improving efficiency and ensuring timely product release
  • Insights into how digital PCR technology enhances testing accuracy and sensitivity, detecting contaminants quickly and reliably
  • Real-world case studies on rapid testing implementations in the field of cell and gene therapy

The session will discuss future trends in sterility testing and showcase successful rapid sterility testing in cell and gene therapy products, demonstrating practical applications and benefits.

Register now to join the discussion

Having been valued at $27.04 billion in 2022, the pharmaceutical packaging and labelling market in Europe is expected to expand at a compound annual growth rate (CAGR) of 4.78 percent up to 2028.

Europe’s position in the global pharmaceutical packaging and labelling market

The authors highlighted that Europe led the worldwide market at 27 percent in 2022. Contributing factors include greater demand for prescription drugs, advancements in the designing and printing of labels, high investments as well as pharmaceutical sales, plus high research and development (R&D) expenditures on pharmaceuticals and government initiatives.

Based on end-user segmentation, the market report on Europe’s pharmaceutical packaging market stated that the pharmaceutical companies segment accounted for the highest share of 45.99 percent in 2022. This is projected to grow at the highest compound annual growth rate of 5.27 percent between the forecast period: 2023 and 2028. The authors wrote that driving factors include increasing demand for branded drugs, over the counter medicines as well as specialty medicine.

Packaging materials

As an “integral part of the pharmaceutical product”, the report authors stated that within the packaging segment in this market, in 2022, the primary packaging segment held the highest share of 70.40 percent. This is expected to grow at the highest compound annual growth rate of 5.01 percent between the forecast period 2023-2028. Specifically, growing demand for medicine packaging such as blister packs, bottles, vials, ampoules, sachet, pouches, and bags are influencing the medicine packaging and labelling market in Europe.

In terms of material type, paper was reported to hold the highest share of 39.76 percent in 2022. This share is predicted to grow at a compound annual growth rate of 4.80 percent during the forecast period. Sustainability, specifically recyclable material, was noted as a key contributor to this rising demand in the pharmaceutical packaging market.

AI-supported spectroscopy delivers superior pharmaceutical packaging QC

Share via
Share via